$121.59
0.28%The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Quality against peers; 50 is the peer median.
PM peer median: the typical company the value is compared with. The /100 is its score against those peers.